Leerink Partners Raises Price Target on UnitedHealth Group (UNH) Following 3Q Report
Get Alerts UNH Hot Sheet
Rating Summary:
28 Buy, 5 Hold, 2 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Leerink Partners reiterated an Outperform rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $175.00 (from $165.00), following the company's 3Q earnings report. Management expressed comfort with the $9.10 2017 EPS, confirming expectations that guidance on Nov. 29 I-Day will bracket consensus with upside. 2016 EPS estimates were raised to $8.02 and 2017 to $9.17 with expected revenue, net income and EPS medium term growth at 12%, 16% and 17%, respectively.
Analyst Ana Gupte commented, "UNH's solid "Beat & Raise" 3Q with a 9c EPS beat and 13c raise gives us more confidence in the strength of their diversified platform and execution while also offering positive readacross for Commercial Fully Insured & Individual fundamentals to the rest of the group."
For an analyst ratings summary and ratings history on UnitedHealth Group click here. For more ratings news on UnitedHealth Group click here.
Shares of UnitedHealth Group closed at $143.39 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teleperformance (TEP:FP) (TLPFY) PT Lowered to EUR125 at RBC Capital, 'perceived risk profile makes it a no-fly zone for many investors'
- UPS (UPS) PT Lowered to $150 at HSBC, 'on lower multiple to reflect continued de-rating'
- Midday movers: RH, Estee Lauder rise; Tesla falls
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!